Literature DB >> 22898778

Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth.

Xiangjian Zheng1, Chong Xu, Annie O Smith, Amber N Stratman, Zhiying Zou, Benjamin Kleaveland, Lijun Yuan, Chuka Didiku, Aslihan Sen, Xi Liu, Nicolas Skuli, Alexander Zaslavsky, Mei Chen, Lan Cheng, George E Davis, Mark L Kahn.   

Abstract

Cardiovascular growth must balance stabilizing signals required to maintain endothelial connections and network integrity with destabilizing signals that enable individual endothelial cells to migrate and proliferate. The cerebral cavernous malformation (CCM) signaling pathway utilizes the adaptor protein CCM2 to strengthen endothelial cell junctions and stabilize vessels. Here we identify a CCM2 paralog, CCM2L, that is expressed selectively in endothelial cells during periods of active cardiovascular growth. CCM2L competitively blocks CCM2-mediated stabilizing signals biochemically, in cultured endothelial cells, and in developing mice. Loss of CCM2L reduces endocardial growth factor expression and impairs tumor growth and wound healing. Our studies identify CCM2L as a molecular mechanism by which endothelial cells coordinately regulate vessel stability and growth during cardiovascular development, as well as postnatal vessel growth.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898778      PMCID: PMC3743537          DOI: 10.1016/j.devcel.2012.06.004

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  33 in total

Review 1.  Molecular mechanisms of blood vessel growth.

Authors:  E M Conway; D Collen; P Carmeliet
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

2.  Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.

Authors:  Ryo Iwamoto; Satoru Yamazaki; Masanori Asakura; Seiji Takashima; Hidetoshi Hasuwa; Kenji Miyado; Satoshi Adachi; Masafumi Kitakaze; Koji Hashimoto; Gerhard Raab; Daisuke Nanba; Shigeki Higashiyama; Masatsugu Hori; Michael Klagsbrun; Eisuke Mekada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-05       Impact factor: 11.205

3.  Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.

Authors:  D Lyden; K Hattori; S Dias; C Costa; P Blaikie; L Butros; A Chadburn; B Heissig; W Marks; L Witte; Y Wu; D Hicklin; Z Zhu; N R Hackett; R G Crystal; M A Moore; K A Hajjar; K Manova; R Benezra; S Rafii
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

4.  Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice.

Authors:  Shun Yan Lu; Yan Jin; Xiaodong Li; Patricia Sheppard; Margaret E Bock; Farah Sheikh; Mary Lynn Duckworth; Peter A Cattini
Journal:  DNA Cell Biol       Date:  2010-08       Impact factor: 3.311

5.  heart of glass regulates the concentric growth of the heart in zebrafish.

Authors:  John D Mably; Manzoor Ali P K Mohideen; C Geoffrey Burns; Jau-Nian Chen; Mark C Fishman
Journal:  Curr Biol       Date:  2003-12-16       Impact factor: 10.834

6.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.

Authors:  M Gassmann; F Casagranda; D Orioli; H Simon; C Lai; R Klein; G Lemke
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes.

Authors:  Peggy C Stolt; Hyesung Jeon; Hyun Kyu Song; Joachim Herz; Michael J Eck; Stephen C Blacklow
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

8.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.

Authors:  Kevin J Whitehead; Nicholas W Plummer; Jennifer A Adams; Douglas A Marchuk; Dean Y Li
Journal:  Development       Date:  2004-03       Impact factor: 6.868

10.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

View more
  30 in total

Review 1.  Endothelial cell-cell adhesion during zebrafish vascular development.

Authors:  Anne K Lagendijk; Alpha S Yap; Benjamin M Hogan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 2.  PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.

Authors:  Souvik Kar; Amir Samii; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2014-11-19       Impact factor: 3.042

Review 3.  CCM1 and the second life of proteins in adhesion complexes.

Authors:  Maaike C W van den Berg; Boudewijn M T Burgering
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 4.  Cerebral cavernous malformation proteins at a glance.

Authors:  Kyle M Draheim; Oriana S Fisher; Titus J Boggon; David A Calderwood
Journal:  J Cell Sci       Date:  2014-01-30       Impact factor: 5.285

5.  Genome-Wide Association Study of Growth and Body-Shape-Related Traits in Large Yellow Croaker (Larimichthys crocea) Using ddRAD Sequencing.

Authors:  Zhixiong Zhou; Kunhuang Han; Yidi Wu; Huaqiang Bai; Qiaozhen Ke; Fei Pu; Yilei Wang; Peng Xu
Journal:  Mar Biotechnol (NY)       Date:  2019-07-22       Impact factor: 3.619

Review 6.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

7.  ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.

Authors:  Jonathan N Rosen; Vanessa M Sogah; Lillian Y Ye; John D Mably
Journal:  Dev Biol       Date:  2013-01-15       Impact factor: 3.582

8.  Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.

Authors:  Ujala Rana; Zhong Liu; Suresh N Kumar; Baofeng Zhao; Wenquan Hu; Michelle Bordas; Stephanie Cossette; Sara Szabo; Jamie Foeckler; Hartmut Weiler; Magdalena Chrzanowska-Wodnicka; Mary L Holtz; Ravindra P Misra; Valerie Salato; Paula E North; Ramani Ramchandran; Qing Robert Miao
Journal:  Dev Biol       Date:  2015-12-31       Impact factor: 3.582

9.  Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model.

Authors:  Jaesung P Choi; Xi Yang; Matthew Foley; Xian Wang; Xiangjian Zheng
Journal:  J Vis Exp       Date:  2017-09-04       Impact factor: 1.355

10.  The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.

Authors:  Xavier Cullere; Eva Plovie; Paul M Bennett; Calum A MacRae; Tanya N Mayadas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.